Complete Filing Data
BIODESIX INC reported Stockholders Equity of -$2.47 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BIODESIX INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$35.3M | -$42.9M | -$52.1M | -$65.4M | -$43.2M | -$65.4M | -$30.7M |
| Selling General And Administrative Expense | $87.5M | $80.5M | $67.4M | $61.5M | $50.5M | $34.9M | $30.6M |
| Revenues | $88.5M | $71.3M | $49.1M | $38.2M | $54.5M | $45.6M | $24.6M |
| Research And Development Expense | $12.0M | $9.6M | $10.0M | $13.1M | $12.8M | $10.8M | $10.5M |
| Operating Income Loss | -$27.9M | -$34.5M | -$41.3M | -$50.6M | -$40.9M | -$22.9M | -$26.7M |
| Operating Expenses | $116.4M | $105.8M | $90.4M | $88.8M | $95.4M | $68.5M | $51.3M |
| Other Nonoperating Income Expense | -$10.8M | -$14.9M | -$2.2M | -$8.4M | -$4.0M | ||
| Interest Expense | $9.5M | $8.1M | $4.5M | $7.6M | $3.0M | ||
| Other Nonoperating Income | $604.0K | $73.0K | $6.0K | $109.0K | $9.0K | $440.0K | $1.1M |
| Impairment Of Intangible Assets Finitelived | $107.0K | $238.0K | $44.0K | $81.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$8.7M | -$11.5M | -$11.1M | -$10.3M | -$10.8M | -$13.6M | -$10.9M | -$13.4M | -$18.7M | -$13.7M | -$15.8M | -$15.6M | -$11.5M | -$11.4M | -$7.0M | -$8.8M | -$8.3M | -$9.7M | -$9.6M | -$6.9M | -$7.7M |
| Selling General And Administrative Expense | $21.7M | $22.4M | $20.4M | $20.0M | $19.7M | $20.6M | $15.5M | $16.7M | $19.0M | $15.1M | $15.2M | $14.5M | $13.6M | $11.4M | $11.9M | $7.9M | $6.8M | $8.1M | $8.2M | ||
| Revenues | $21.8M | $20.0M | $18.0M | $18.2M | $17.9M | $14.8M | $13.5M | $11.9M | $9.1M | $11.1M | $11.0M | $6.5M | $6.5M | $11.9M | $28.9M | $9.2M | $4.2M | $5.1M | $3.9M | ||
| Research And Development Expense | $3.0M | $3.3M | $2.9M | $2.5M | $2.6M | $2.0M | $1.9M | $2.9M | $3.3M | $3.0M | $3.4M | $3.2M | $3.3M | $3.3M | $3.3M | $2.7M | $2.1M | $2.9M | $2.4M | ||
| Operating Income Loss | -$7.1M | -$9.7M | -$9.1M | -$8.6M | -$8.2M | -$11.0M | -$7.2M | -$10.9M | -$16.4M | -$10.6M | -$11.6M | -$14.5M | -$13.1M | -$10.6M | -$5.6M | -$6.2M | -$5.6M | -$8.4M | -$9.0M | ||
| Operating Expenses | $28.8M | $29.7M | $27.1M | $26.7M | $26.2M | $25.8M | $20.7M | $22.8M | $25.4M | $21.7M | $22.6M | $21.0M | $19.6M | $22.5M | $34.4M | $15.4M | $9.9M | $13.5M | $13.0M | ||
| Other Nonoperating Income Expense | $409.0K | $51.0K | $98.0K | $374.0K | -$387.0K | -$64.0K | $2.0K | $1.0K | $1.0K | -$3.1M | -$4.2M | -$1.1M | $1.6M | -$815.0K | -$1.4M | -$2.6M | -$2.6M | -$1.3M | $133.0K | ||
| Interest Expense | $1.9M | $2.5M | $2.4M | $2.4M | $2.4M | $3.0M | $1.3M | $1.1M | $1.5M | $815.0K | $651.0K | $2.7M | $2.8M | $1.5M | $706.0K | ||||||
| Other Nonoperating Income | $2.0K | $1.0K | $1.0K | $2.0K | $100.0K | $12.0K | $1.0K | $77.0K | $133.0K | $123.0K | |||||||||||
| Impairment Of Intangible Assets Finitelived | $7.0K | $26.0K | $73.0K | $67.0K | $68.0K | $20.0K | $81.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$2.5M | $20.9M | $4.6M | $20.6M | $19.7M | $41.2M | -$225.1M | -$194.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $19.1M | $26.3M | $26.4M | $43.2M | $32.8M | $62.3M | $5.5M | $6.1M |
| Goodwill | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $14.2M |
| Retained Earnings Accumulated Deficit | -$497.8M | -$462.5M | -$419.6M | -$367.4M | -$302.0M | -$258.8M | -$227.5M | |
| Property Plant And Equipment Net | $24.8M | $27.8M | $27.9M | $5.8M | $4.2M | $3.2M | $2.1M | |
| Other Liabilities Noncurrent | $1.0M | $815.0K | $712.0K | $558.0K | $1.4M | $1.9M | $358.0K | |
| Other Assets Current | $4.5M | $4.6M | $5.7M | $5.2M | $7.2M | $8.7M | $2.1M | |
| Long Term Notes Payable | $47.4M | $36.4M | $35.2M | $25.0M | $10.0M | $15.9M | $23.8M | |
| Liabilities Noncurrent | $72.5M | $62.1M | $61.1M | $49.5M | $27.4M | $47.8M | $53.6M | |
| Liabilities Current | $17.4M | $14.3M | $33.4M | $22.8M | $29.0M | $32.1M | $22.6M | |
| Liabilities And Stockholders Equity | $87.5M | $97.2M | $99.1M | $92.9M | $76.1M | $121.1M | $45.0M | |
| Liabilities | $89.9M | $76.4M | $94.5M | $72.3M | $56.4M | $79.9M | $76.2M | |
| Intangible Assets Net Excluding Goodwill | $3.9M | $5.9M | $7.9M | $9.8M | $11.6M | $13.3M | $15.1M | |
| Contract With Customer Liability Current | $961.0K | $678.0K | $324.0K | $962.0K | $1.9M | $3.5M | $1.3M | |
| Common Stock Value | $8.0K | $7.0K | $96.0K | $78.0K | $31.0K | $27.0K | $1.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.3M | -$39.0K | -$16.8M | $10.4M | -$29.5M | $56.8M | -$626.0K | |
| Cash And Cash Equivalents At Carrying Value | $19.0M | $26.2M | $26.3M | $43.1M | $32.7M | $62.1M | $5.3M | |
| Assets Noncurrent | $55.0M | $57.8M | $59.4M | $39.6M | $32.5M | $34.9M | $32.3M | |
| Assets Current | $32.5M | $39.5M | $39.7M | $53.3M | $43.6M | $86.1M | $12.7M | |
| Assets | $87.5M | $97.2M | $99.1M | $92.9M | $76.1M | $121.1M | $45.0M | |
| Accrued Liabilities Current | $11.0M | $10.1M | $7.7M | $8.2M | $7.7M | $7.8M | $4.2M | |
| Accounts Receivable Net Current | $9.0M | $8.6M | $7.7M | $5.1M | $3.7M | $15.3M | $5.3M | |
| Accounts Payable Current | $3.1M | $2.2M | $2.9M | $1.7M | $1.7M | $9.0M | $1.7M | |
| Notes Payable To Bank Current | $6.0K | $21.0K | $51.0K | $49.0K | $19.0K | $11.8M | $12.2M | |
| Other Assets Noncurrent | $8.2M | $7.3M | $6.9M | $5.9M | $1.7M | $3.5M | $90.0K | |
| Allowance For Doubtful Accounts Receivable | $62.0K | $481.0K | $65.0K | $118.0K | $158.0K | $180.0K | ||
| Accrued Interest Amortization Of Debt Issuance Costs And Other | $1.3M | $2.5M | $5.1M | $5.0M | $2.7M | $1.4M | ||
| Repayments Of Long Term Debt | $21.0K | $51.0K | $49.0K | $28.6M | $45.4M | |||
| Operating Lease Right Of Use Asset | $3.0M | $1.8M | $1.7M | $3.0M | $1.3M | |||
| Gains Losses On Extinguishment Of Debt | -$248.0K | -$7.0M | $2.3M | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $644.0K | $583.0K | $797.0K | $3.9M | ||||
| Other Liabilities Current | $992.0K | $641.0K | $293.0K | $41.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.7M | $1.1M | $11.1M | $27.9M | $36.3M | -$5.5M | -$1.4M | -$7.0M | $4.6M | -$2.9M | $7.7M | $7.8M | $16.0M | $25.8M | $36.4M | -$251.8M | -$243.0M | -$234.8M | -$222.1M | -$212.5M | -$205.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.7M | $20.8M | $17.7M | $31.5M | $42.3M | $11.6M | $19.9M | $17.5M | $25.4M | $15.3M | $28.7M | $16.5M | $48.0M | $56.4M | $55.4M | $6.5M | $11.9M | $7.0M | $9.1M | ||
| Goodwill | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $15.0M | $11.6M | |||||
| Retained Earnings Accumulated Deficit | -$493.8M | -$485.1M | -$473.6M | -$454.2M | -$444.0M | -$433.2M | -$410.4M | -$399.5M | -$386.1M | -$347.1M | -$333.4M | -$317.6M | -$288.7M | -$277.2M | -$265.8M | -$257.7M | |||||
| Property Plant And Equipment Net | $25.5M | $26.1M | $27.0M | $28.7M | $28.0M | $28.6M | $25.4M | $19.0M | $13.1M | $4.3M | $4.0M | $4.0M | $4.4M | $3.4M | $3.4M | $3.0M | |||||
| Other Liabilities Noncurrent | $769.0K | $549.0K | $692.0K | $620.0K | $744.0K | $615.0K | $815.0K | $896.0K | $648.0K | $60.0K | $70.0K | $615.0K | $1.5M | $1.6M | $1.7M | $392.0K | |||||
| Other Assets Current | $4.1M | $4.3M | $4.4M | $4.6M | $5.2M | $7.1M | $3.3M | $3.7M | $4.6M | $4.5M | $6.0M | $7.0M | $5.7M | $6.8M | $7.5M | $6.4M | |||||
| Long Term Notes Payable | $47.1M | $46.8M | $36.7M | $36.1M | $35.8M | $35.5M | $25.0M | $24.7M | $25.1M | $4.9M | $8.6M | $10.1M | $30.0M | $30.0M | $30.3M | $17.2M | |||||
| Liabilities Noncurrent | $72.3M | $71.4M | $61.9M | $61.9M | $62.0M | $61.5M | $55.6M | $56.7M | $54.1M | $28.7M | $34.5M | $24.1M | $51.2M | $54.8M | $62.9M | $51.2M | |||||
| Liabilities Current | $18.2M | $15.2M | $13.3M | $13.0M | $17.6M | $31.2M | $32.6M | $28.0M | $22.1M | $37.4M | $33.1M | $29.8M | $22.8M | $21.3M | $16.1M | $56.6M | |||||
| Liabilities And Stockholders Equity | $88.7M | $87.7M | $86.2M | $102.7M | $115.8M | $87.2M | $86.8M | $77.6M | $80.8M | $63.2M | $75.2M | $61.7M | $90.0M | $101.8M | $115.5M | $46.5M | |||||
| Liabilities | $90.4M | $86.6M | $75.2M | $74.9M | $79.6M | $92.7M | $88.2M | $84.6M | $76.2M | $66.1M | $67.6M | $53.9M | $74.0M | $76.0M | $79.1M | $107.8M | |||||
| Intangible Assets Net Excluding Goodwill | $4.4M | $4.9M | $5.4M | $6.4M | $6.9M | $7.4M | $8.4M | $8.9M | $9.3M | $10.2M | $10.7M | $11.1M | $12.0M | $12.4M | $12.8M | $13.7M | |||||
| Contract With Customer Liability Current | $2.8M | $617.0K | $788.0K | $676.0K | $447.0K | $313.0K | $659.0K | $1.1M | $1.1M | $1.6M | $2.2M | $2.5M | $1.8M | $2.2M | $2.4M | $5.7M | |||||
| Common Stock Value | $8.0K | $146.0K | $146.0K | $145.0K | $145.0K | $97.0K | $88.0K | $79.0K | $78.0K | $41.0K | $40.0K | $32.0K | $27.0K | $27.0K | $27.0K | $2.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$8.6M | -$14.8M | -$17.8M | -$16.3M | -$6.9M | $1.5M | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $16.6M | $20.7M | $17.6M | $31.4M | $42.2M | $11.5M | $19.8M | $17.4M | $25.3M | $15.2M | $23.6M | $16.4M | $47.9M | $56.3M | $55.3M | $6.3M | |||||
| Assets Noncurrent | $55.3M | $55.3M | $56.6M | $58.7M | $58.3M | $58.7M | $57.9M | $52.4M | $46.0M | $39.1M | $40.2M | $34.4M | $33.6M | $33.4M | $34.2M | $28.4M | |||||
| Assets Current | $33.4M | $32.4M | $29.6M | $44.0M | $57.6M | $28.5M | $28.9M | $25.2M | $34.8M | $24.1M | $35.1M | $27.2M | $56.4M | $68.5M | $81.2M | $18.1M | |||||
| Assets | $88.7M | $87.7M | $86.2M | $102.7M | $115.8M | $87.2M | $86.8M | $77.6M | $80.8M | $63.2M | $75.2M | $61.7M | $90.0M | $101.8M | $115.5M | $46.5M | |||||
| Accrued Liabilities Current | $9.7M | $9.7M | $7.4M | $8.6M | $8.3M | $7.9M | $6.9M | $7.0M | $5.7M | $6.7M | $6.7M | $6.2M | $6.3M | $6.2M | $7.3M | $7.0M | |||||
| Accounts Receivable Net Current | $12.7M | $7.5M | $7.6M | $8.0M | $10.1M | $9.9M | $5.8M | $4.1M | $4.9M | $4.4M | $5.5M | $3.8M | $2.8M | $5.3M | $18.4M | $5.4M | |||||
| Accounts Payable Current | $3.6M | $3.0M | $2.9M | $2.5M | $2.2M | $3.2M | $2.9M | $3.5M | $1.6M | $2.1M | $1.8M | $2.1M | $1.6M | $1.2M | $3.7M | $3.5M | |||||
| Notes Payable To Bank Current | $11.0K | $16.0K | $18.0K | $29.0K | $37.0K | $45.0K | $50.0K | $50.0K | $50.0K | $14.3M | $11.8M | $51.0K | $20.0K | $3.1M | $2.7M | $7.2M | |||||
| Other Assets Noncurrent | $7.5M | $7.2M | $7.3M | $6.7M | $6.6M | $6.2M | $7.0M | $7.0M | $6.4M | $6.1M | $1.6M | $2.0M | $2.1M | $2.5M | $3.0M | ||||||
| Allowance For Doubtful Accounts Receivable | $35.0K | $76.0K | $209.0K | $246.0K | $238.0K | $161.0K | $57.0K | $150.0K | $200.0K | $50.0K | $52.0K | $100.0K | $168.0K | $168.0K | |||||||
| Accrued Interest Amortization Of Debt Issuance Costs And Other | $309.0K | $1.1M | $1.4M | $1.0M | $65.0K | ||||||||||||||||
| Repayments Of Long Term Debt | $7.0K | $13.0K | $12.0K | $11.0K | $25.4M | ||||||||||||||||
| Operating Lease Right Of Use Asset | $2.9M | $2.1M | $2.0M | $1.9M | $1.8M | $1.6M | $2.1M | $2.5M | $2.2M | $3.5M | $4.0M | $2.2M | |||||||||
| Gains Losses On Extinguishment Of Debt | -$248.0K | -$52.0K | -$3.0M | $3.1M | -$728.0K | ||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $45.0K | $338.0K | $43.0K | $1.2M | |||||||||||||||||
| Other Liabilities Current | $637.0K | $638.0K | $1.1M | $544.0K | $386.0K | $294.0K | $1.7M | $285.0K | $144.0K | $1.9M | $1.1M | $37.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $259.0K | $3.2M | $22.9M | $3.3M | $2.2M | $1.9M | $1.3M |
| Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net | $144.0K | $210.0K | $143.0K | $236.0K | $306.0K | $232.0K | $106.0K |
| Net Cash Provided By Used In Operating Activities | -$23.3M | -$48.6M | -$22.9M | -$45.0M | -$28.2M | -$21.4M | -$21.7M |
| Net Cash Provided By Used In Investing Activities | -$403.0K | -$3.4M | -$23.1M | -$3.5M | -$2.5M | -$2.9M | -$1.9M |
| Net Cash Provided By Used In Financing Activities | $16.4M | $52.1M | $29.1M | $58.9M | $1.3M | $81.1M | $23.0M |
| Increase Decrease In Other Current Assets | $258.0K | -$716.0K | -$905.0K | -$1.1M | -$1.4M | $6.6M | -$1.0K |
| Increase Decrease In Contract With Customer Liability | $174.0K | $248.0K | -$755.0K | -$1.2M | -$1.7M | $2.2M | $791.0K |
| Increase Decrease In Accounts Receivable | $531.0K | $1.8M | $4.7M | $1.5M | -$11.5M | $10.3M | $3.6M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.9M | $1.6M | $513.0K | -$773.0K | -$7.4M | $11.7M | $1.2M |
| Share Based Compensation | $4.1M | $6.6M | $5.4M | $6.0M | $4.9M | $3.7M | $170.0K |
| Proceeds From Stock Options Exercised | $25.0K | $91.0K | $269.0K | $769.0K | $1.3M | $47.0K | |
| Proceeds From Payments For Other Financing Activities | -$817.0K | -$445.0K | -$188.0K | -$33.0K | -$6.0K | -$116.0K | |
| Payments Of Debt Issuance Costs | $30.0K | $44.0K | $833.0K | $3.7M | $164.0K | ||
| Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan | $497.0K | $625.0K | $643.0K | $355.0K | $328.0K | ||
| Increase Decrease In Other Noncurrent Assets | $121.0K | -$68.0K | -$33.0K | $3.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $74.0K | $234.0K | $7.7M | $262.0K | $466.0K | $98.0K |
| Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net | $63.0K | $39.0K | $30.0K | $90.0K | $50.0K | $44.0K |
| Net Cash Provided By Used In Operating Activities | -$8.6M | -$15.3M | -$7.7M | -$13.1M | -$11.3M | -$4.5M |
| Net Cash Provided By Used In Investing Activities | -$137.0K | -$273.0K | -$7.7M | -$352.0K | -$516.0K | -$392.0K |
| Net Cash Provided By Used In Financing Activities | $97.0K | $791.0K | -$2.4M | -$2.8M | $5.0M | $6.4M |
| Increase Decrease In Other Current Assets | -$215.0K | $425.0K | -$544.0K | $166.0K | -$1.1M | $85.0K |
| Increase Decrease In Contract With Customer Liability | $83.0K | -$37.0K | $129.0K | -$124.0K | -$1.1M | -$567.0K |
| Increase Decrease In Accounts Receivable | -$904.0K | $2.3M | $33.0K | $78.0K | $3.3M | -$2.5M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$1.9M | -$1.2M | -$2.0M | -$1.3M | -$5.7M | $857.0K |
| Share Based Compensation | $972.0K | $2.6M | $2.3M | $1.3M | $1.8M | |
| Proceeds From Stock Options Exercised | $3.0K | $6.0K | $75.0K | $475.0K | $11.0K | |
| Proceeds From Payments For Other Financing Activities | -$198.0K | -$70.0K | -$34.0K | -$6.0K | ||
| Payments Of Debt Issuance Costs | $11.0K | $18.0K | $801.0K | $108.0K | ||
| Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan | $313.0K | $282.0K | $420.0K | $202.0K | ||
| Increase Decrease In Other Noncurrent Assets | -$15.0K | $22.0K | $10.0K | -$466.0K | -$224.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$4.67 | -$6.64 | -$0.64 | -$1.55 | -$1.58 | -$6.48 | -$126.97 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 190.0M |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 7.6M | 6.5M | 82.1M | 42.1M | 27.4M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 7.6M | 6.5M | 82.1M | 42.1M | 27.4M | ||
| Common Stock Shares Outstanding | 8.3M | 7.3M | 96.2M | 77.6M | 30.8M | 26.6M | 254.9K |
| Common Stock Shares Issued | 8.3M | 7.3M | 96.2M | 77.6M | 30.8M | 26.6M | 254.9K |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share Basic | $-4.67 | $-6.64 | $-0.64 | $-1.55 | $-1.58 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.16 | -$0.08 | -$0.08 | -$1.40 | -$0.08 | -$0.14 | -$0.14 | -$0.17 | -$0.24 | -$0.34 | -$0.40 | -$0.50 | -$0.41 | -$0.41 | -$0.41 | -$31.93 | -$30.06 | -$37.18 | -$39.35 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 220.0M | |||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 7.5M | 146.7M | 146.5M | 7.3M | 127.2M | 97.2M | 79.7M | 78.5M | 77.8M | 40.4M | 39.2M | 31.1M | 28.1M | 2.5M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 7.5M | 146.7M | 146.5M | 7.3M | 127.2M | 97.2M | 79.7M | 78.5M | 77.8M | 40.4M | 39.2M | 31.1M | 28.1M | 2.5M | |||||
| Common Stock Shares Outstanding | 8.0M | 146.6M | 146.4M | 145.5M | 145.1M | 97.2M | 88.3M | 78.6M | 78.0M | 41.2M | 40.0M | 31.9M | 27.0M | 26.9M | 26.8M | 289.5K | |||
| Common Stock Shares Issued | 8.0M | 146.6M | 146.4M | 145.5M | 145.1M | 97.2M | 88.3M | 78.6M | 78.0M | 41.2M | 40.0M | 31.9M | 27.0M | 26.9M | 26.8M | 289.5K | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Earnings Per Share Basic | $-1.16 | $-0.08 | $-0.08 | $-1.40 | $-0.08 | $-0.14 | $-0.14 | $-0.17 | $-0.24 | $-0.34 | $-0.40 | $-0.50 | $-0.41 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.1M | $6.6M | $5.4M | $6.0M | $4.9M | $3.7M | $170.0K |
| Stock Issued During Period Value Stock Options Exercised | $24.0K | $91.0K | $269.0K | $769.0K | $1.3M | $47.0K | |
| Direct Costs And Expenses | $16.7M | $15.6M | $13.0M | $14.2M | $30.5M | $22.0M | $6.1M |
| Depreciation And Amortization | $5.7M | $5.8M | $3.3M | $3.6M | $3.2M | $2.9M | $2.8M |
| Stock Issued During Period Value New Issues | $6.8M | $18.8M | $28.0M | $56.2M | $15.7M | $63.8M | |
| Additional Paid In Capital | $495.3M | $483.4M | $424.1M | $387.9M | $321.7M | $300.0M | $2.3M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $497.0K | $625.0K | $643.0K | $355.0K | $328.0K | ||
| Interest Paid Net | $6.4M | $7.0M | $4.0M | $1.0M | $1.7M | $1.8M | $1.8M |
| Provision For Doubtful Accounts | $497.0K | $93.0K | $193.0K | $296.0K | $246.0K | ||
| Fair Value Adjustment Of Warrants | $280.0K | $1.3M | -$84.0K | $1.3M | $104.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.1M | $1.0M | $972.0K | $1.5M | $1.2M | $2.6M | $954.0K | $1.1M | $2.3M | $1.2M | $1.4M | $1.3M | $1.4M | $539.0K | $1.8M | $100.0K | $55.0K | $45.0K | $49.0K | $31.0K | |
| Stock Issued During Period Value Stock Options Exercised | $12.0K | $4.0K | $3.0K | $3.0K | $81.0K | $6.0K | $57.0K | $17.0K | $75.0K | $60.0K | $204.0K | $475.0K | $14.0K | $11.0K | $16.0K | $1.0K | $30.0K | ||||
| Direct Costs And Expenses | $4.1M | $4.0M | $3.7M | $4.2M | $3.9M | $3.2M | $3.2M | $3.2M | $3.2M | $3.6M | $4.0M | $3.2M | $2.7M | $7.1M | $18.2M | $3.9M | $1.9M | $1.6M | $1.5M | ||
| Depreciation And Amortization | $1.4M | $1.4M | $1.4M | $1.5M | $1.4M | $1.4M | $785.0K | $908.0K | $746.0K | $678.0K | |||||||||||
| Stock Issued During Period Value New Issues | $4.6M | -$15.0K | $18.2M | $607.0K | $15.3M | -$61.0K | $1.7M | $14.3M | $1.4M | ||||||||||||
| Additional Paid In Capital | $492.1M | $486.1M | $484.5M | $482.0M | $480.1M | $427.6M | $408.9M | $392.4M | $390.6M | $344.1M | $341.0M | $325.3M | $304.7M | $302.9M | $302.2M | $2.5M | |||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $184.0K | $313.0K | $343.0K | $282.0K | $223.0K | $420.0K | $153.0K | $202.0K | $328.0K | ||||||||||||
| Interest Paid Net | $1.4M | $1.5M | $1.0M | $223.0K | $577.0K | ||||||||||||||||
| Provision For Doubtful Accounts | $129.0K | $198.0K | -$39.0K | $193.0K | -$3.0K | ||||||||||||||||
| Fair Value Adjustment Of Warrants | -$98.0K | $378.0K | $1.4M | -$61.0K | $24.0K | -$4.0K | -$51.0K |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.